Abstract:Objective: Patients with untreated severe aortic regurgitation (AR) have a high risk of mortality. Transfemoral transcatheter aortic valve replacement (TF-TAVR) is a treatment option for AR; however, the safety and efficacy of this technique have not been sufficiently established. This study aimed to evaluate the clinical and anatomical variables correlating with device success of TF-TAVR using a self-expanding valve system for pure AR. Methods: Patients with pure native severe AR who underwent TF-TAVR using a self-expanding valve system were registered at 5 Chinese centers. The primary endpoint was device success at 1 month after TAVR. The secondary endpoint was the composite of major adverse cardiovascular events (MACE) at 6 months, including all-cause death, ischemic stroke, emergency conversion to cardiac surgery, and permanent pacemaker implantation. Echocardiography was used to analyze the left ventricular function before the TAVR procedure and during follow-up. Multivariable logistic regression and Cox regression analyses were performed to find relevant independent risk factors. Results: Between September 2019 and February 2022, 79 patients with AR were enrolled in the study. At 1 month, device success was achieved in 60 (75.9%) patients. By 6 months, 29 (36.7%) patients had MACE. Echocardiography revealed improved left ventricular function after TAVR. Multivariate regression analysis demonstrated that the Society of Thoracic Surgeons (STS) risk score (odds ratio (OR) 0.760, 95% confidence interval (CI): 0.584–0.989; P = 0.041) and annulus perimeter (OR 0.888, 95% CI: 0.796–0.992; P = 0.035) were 2 predictors of device success. Moreover, annulus perimeter (<80.2 mm), but not STS risk score, was associated with a significant reduction in MACE at 6 months (hazard ratio (HR) 2.223, 95% CI: 1.060–4.659; P = 0.028). Conclusions: TF-TAVR using a self-expanding valve system appears to be a safe and feasible treatment for patients with pure native severe AR, particularly those with a less enlarged annulus.

Chinese expert consensus on transfemoral transcatheter aortic valve replacement for pure aortic regurgitation (2023)

Technical Details of Thoracic Endovascular Aortic Repair with Fenestrations for Thoracic Aortic Pathologies Involving the Aortic Arch: A Chinese Expert Consensus

Interpretation of 2015 Experts Consensus for Transcatheter Aortic Valve Replacement

Severe Symptomatic Bicuspid and Tricuspid Aortic Stenosis in China: Characteristics and Outcomes of Transcatheter Aortic Valve Replacement with the Venus-A Valve (vol 2, pg 60, 2018)

Transcatheter Aortic Valve Replacement in Patients with Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

Expansion of indications for transcatheter aortic valve replacement

An Updated Comprehensive Review of Existing Transcatheter Aortic Valve Replacement Access

[Chinese guideline for the clincal application of transcatheter aortic valve replacement]

Transcatheter “sandwich” Valve-in-Valve Implantation Technique for Pure Aortic Regurgitation: Operation Skills and Single Center Experience

Transcatheter “Sandwich” Valve-in-Valve Implantation Technique for Pure Aortic Regurgitation: Operation Skills and Early Experience

Clinical practice and prognosis of emergent transcatheter aortic valve replacement

Transcatheter Aortic Valve Replacement for Bicuspid Vs. Tricuspid Aortic Stenosis among Patients at Low Surgical Risk in China: from the Multicenter National NTCVR Database

Transcatheter aortic valve replacement in China - a review of the available evidence

A novel anatomic classification to guide transcatheter aortic valve replacement for pure aortic regurgitation

Morphological Characteristics of Severe Aortic Stenosis in China: Imaging Corelab Observations from the First Chinese Transcatheter Aortic Valve Trial

Transfemoral Transcatheter Aortic Valve Replacement with VitaFlowTM Valve for Pure Native Aortic Regurgitation in Patients with High Surgical Risk: Rationale and Design of a Prospective, Multicenter, and Randomized SEASON-AR Trial.

Trans-apical Transcatheter Aortic Valve Replacement for Patient with Severe Pure Aortic Regurgitation

Transcatheter Aortic Valve Implantation for Aortic Regurgitation: A Comprehensive Review

Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis

Clinical study of anesthesia management and treatment strategies for emergency transcatheter aortic valve replacement

Transcatheter Aortic Valve Replacement for Aortic Regurgitation Caused by Takayasu Arteritis